AI assistant
Sending…
Solid Biosciences Inc. — Director's Dealing 2018
Feb 16, 2018
33003_dirs_2018-02-15_7b6aad22-ddcb-42e2-a932-1941673c5198.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2018-02-14
Reporting Person: Ziolkowski Jennifer Lynn (See Remarks)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-14 | Employee Stock Option (Right to Buy) | $26.23 | A | 66852 | Acquired | 2028-02-14 | Common Stock (66852) | Direct |
Footnotes
F1: The option shall vest in four equal installments beginning on February 14, 2019.
More from Solid Biosciences Inc.
Interim / Quarterly Report
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Mar 19
Annual Report
2026
Mar 19
Major Shareholding Notification
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19